Advances in cfDNA research for pregnancy-related diseases

Advances in cfDNA research for pregnancy-related diseases

Circulating cell-free DNA (cfDNA) comprises extracellular DNA fragments released into bodily fluids through cellular processes such as apoptosis, necrosis, and active secretion. Alterations in cfDNA concentration, fragmentation patterns, and molecular characteristics under physiological and patholog...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yimei Meng, Yu Yan, Xiaoshan Yue, Yan Li, Yanxiang Mo
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-08-01
Series:	Frontiers in Cell and Developmental Biology
Subjects:	cell-free DNA (cfDNA) pregnancy-related disorders non-invasive biomarkers preeclampsia gestational diabetes mellitus
Online Access:	https://www.frontiersin.org/articles/10.3389/fcell.2025.1600532/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Exploration of cfDNA landscape in NIPT and clinical utilities of cfDNA based gene expression inference in prenatal diagnostics
by: Ruo Jia, et al.
Published: (2025-02-01)

Characterization of Ultra-Short plasma Cell-Free DNA in maternal blood and its preliminary potential as a screening marker for preeclampsia
by: Weiqiang Liu, et al.
Published: (2025-07-01)

cfDNA Key genomic markers in HCV-Induced hepatocellular carcinoma in Egyptian patients
by: Mohamed Khalifa, et al.
Published: (2025-09-01)

Comparative analysis of whole-genome sequencing of tumor and cfDNA in a neuroblastoma patient: a case report
by: Susanne Fransson, et al.
Published: (2025-05-01)

TREX1 activators: A novel therapeutic strategy for rheumatoid arthritis management via cfDNA clearance
by: Yuping Wang, et al.
Published: (2025-08-01)

Baseline levels and dynamic changes of cfDNA, tumor fraction and mutations to anticipate the clinical course of small cell lung cancer (SCLC) patients treated with first-line atezolizumab and chemotherapy: an hypothesis generating study (CATS/ML43257)
by: Giulia Pasello, et al.
Published: (2025-06-01)

Cell-Free DNA (cfDNA) Regulates Metabolic Remodeling in the ES-2 Ovarian Carcinoma Cell Line, Influencing Cell Proliferation, Quiescence, and Chemoresistance in a Cell-of-Origin-Specific Manner
by: Isabel Lemos, et al.
Published: (2025-04-01)

Plasma cfDNA multi-omic biomarkers profiling for detection and stratification of gastric carcinoma
by: Shiyi Song, et al.
Published: (2025-06-01)

A liquid biopsy approach detects HCC and identifies GJA4 as a potential biomarker for HBV-HCC via plasma cfDNA methylome profiling
by: Jialing Sun, et al.
Published: (2025-06-01)

Advancing diagnosis and early risk assessment of preeclampsia through noninvasive cell-free DNA methylation profiling
by: Machteld Baetens, et al.
Published: (2024-12-01)

Cell-Free DNA (cfDNA) Regulates Metabolic Remodeling, Sustaining Proliferation, Quiescence, and Migration in MDA-MB-231, a Triple-Negative Breast Carcinoma (TNBC) Cell Line
by: Isabel Lemos, et al.
Published: (2025-03-01)

Unlocking the potential of tumor‐derived DNA in urine for cancer detection: methodological challenges and opportunities
by: Birgit M. M. Wever, et al.
Published: (2025-07-01)

Assessment of cfDNA Levels in Saliva Samples of Stressed Young Adults: Preliminary Study
by: Ekin Çelik, et al.
Published: (2025-04-01)

Liquid Biopsy as a Diagnostic and Monitoring Tool in Glioblastoma
by: Ligia Gabriela Tataranu
Published: (2025-04-01)

A prediction model based on cfDNA concentration and cfDNA methylation biomarkers for lung cancer detection
by: Li Ke, et al.
Published: (2025-08-01)

Liquid Biopsy-Based DNA Methylation Biomarkers for Precision Medicine in Breast Cancer
by: Ieva Sadzeviciene, et al.
Published: (2025-01-01)

Methylated ARHGAP40 DNA as a potential biomarker for early diagnosis in high-grade ovarian serous cancer
by: Jiaxin Chai, et al.
Published: (2025-07-01)

A standardized framework for robust fragmentomic feature extraction from cell-free DNA sequencing data
by: Haichao Wang, et al.
Published: (2025-05-01)

Application of rapid Nanopore metagenomic cell-free DNA sequencing to diagnose bloodstream infections: a prospective observational study
by: Morten Eneberg Nielsen, et al.
Published: (2025-05-01)

Battle of the Biomarkers of Systemic Inflammation
by: Emilia Stec-Martyna, et al.
Published: (2025-04-01)

Imaging and outcome correlates of ctDNA methylation markers in prostate cancer: a comparative, cross-sectional [⁶⁸Ga]Ga-PSMA-11 PET/CT study
by: Kilian Kluge, et al.
Published: (2025-02-01)

Dynamic profiling of Cell-free DNA fragmentation uncovers postprandial metabolic and immune alterations
by: Ziting Zhu, et al.
Published: (2025-03-01)

Multimodal analysis of cell-free DNA enhances differentiation of early-stage breast cancer from benign lesions and healthy individuals
by: Thi Tuong Vi Van, et al.
Published: (2025-08-01)

5-Hydroxymethylcytosine modifications in circulating cell-free DNA: frontiers of cancer detection, monitoring, and prognostic evaluation
by: Danjun Song, et al.
Published: (2025-03-01)

Clinical Utility of ctDNA Analysis in Lung Cancer—A Review
by: Kamil Makar, et al.
Published: (2025-06-01)

Cell-free DNA as a complementary diagnostic tool for neglected tropical diseases towards achieving the WHO NTDs elimination by 2030
by: Priscilla Osei-Poku, et al.
Published: (2025-03-01)

Standardized Workflow and Analytical Validation of Cell-Free DNA Extraction for Liquid Biopsy Using a Magnetic Bead-Based Cartridge System
by: Shivaprasad H. Sathyanarayana, et al.
Published: (2025-07-01)

Maternal plasma cell-free DNA nucleosome footprints can reveal changes in gene expression profiles during pregnancy and pre-eclampsia
by: Kun Li, et al.
Published: (2025-03-01)

NIPT of Maternal Plasma-Originated cfDNA: Applications and Guide for the Implementation
by: Fernández Martínez FJ, et al.
Published: (2025-04-01)

Evaluation of a Decentralized Donor-Derived Cell-Free DNA Assay for Kidney Allograft Rejection Monitoring
by: Alexandre Loupy, et al.
Published: (2024-12-01)

Design, Development, and Clinical Validation of a Novel Kit for Cell-Free DNA Extraction
by: Ekin Çelik, et al.
Published: (2025-07-01)

Deep targeted sequencing of circulating tumor DNA to inform treatment in patients with metastatic castration-resistant prostate cancer
by: Maibritt Nørgaard, et al.
Published: (2025-04-01)

The diagnostic accuracy of circulating free DNA for the detection of KRAS mutation status in colorectal cancer: A meta‐analysis
by: Wenli Xie, et al.
Published: (2019-03-01)

Diagnostic approach to elevated dd-cfDNA with reassuring EMB in heart transplantation
by: Rupinder K. Bahniwal, et al.
Published: (2025-08-01)

Role of circulating tumor DNA and cell-free DNA biomarkers in diagnosis and prognosis of oral cancer - a systematic review
by: Samrina Mohammad, et al.
Published: (2025-04-01)

KF-NIPT: K-mer and fetal fraction-based estimation of chromosomal anomaly from NIPT data
by: Dongin Kim, et al.
Published: (2025-05-01)

Combination of Hotspot Mutations With Methylation and Fragmentomic Profiles to Enhance Multi‐Cancer Early Detection
by: Thi Hue Hanh Nguyen, et al.
Published: (2025-01-01)

GUIDE: a prospective cohort study for blood-based early detection of gastrointestinal cancers using targeted DNA methylation and fragmentomics sequencing
by: Ao Huang, et al.
Published: (2025-06-01)

Integrated Analysis of Cell-Free DNA and Novel Protein Biomarkers for Stratification and Therapy Monitoring in Stage IV Pancreatic Cancer: A Preliminary Study
by: Saskia Hussung, et al.
Published: (2024-12-01)

Expanding the clinical utility of liquid biopsy by using liquid transcriptome and artificial intelligence
by: Maher Albitar, et al.
Published: (2024-12-01)